332 related articles for article (PubMed ID: 32671893)
1. Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy.
Li J; Luo Y; Pu K
Angew Chem Int Ed Engl; 2021 Jun; 60(23):12682-12705. PubMed ID: 32671893
[TBL] [Abstract][Full Text] [Related]
2. Activating Nanomedicines with Electromagnetic Energy for Deep-Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy.
Wang F; Pu K; Li J
Small Methods; 2023 May; 7(5):e2201083. PubMed ID: 36316270
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy.
Wang F; Zhu J; Wang Y; Li J
Nanomaterials (Basel); 2022 May; 12(10):. PubMed ID: 35630880
[TBL] [Abstract][Full Text] [Related]
4. Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors.
Cho H; Kim K
Expert Opin Drug Deliv; 2024 Apr; 21(4):627-638. PubMed ID: 38682272
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
6. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
7. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
8. Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy.
Yang Y; Huang J; Liu M; Qiu Y; Chen Q; Zhao T; Xiao Z; Yang Y; Jiang Y; Huang Q; Ai K
Adv Sci (Weinh); 2023 Jan; 10(2):e2204365. PubMed ID: 36437106
[TBL] [Abstract][Full Text] [Related]
9. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches.
Elzoghby AO; Samir O; Emam HE; Soliman A; Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Nasr ML
Acta Pharm Sin B; 2024 Jun; 14(6):2475-2504. PubMed ID: 38828160
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine-based tumor photothermal therapy synergized immunotherapy.
Shang T; Yu X; Han S; Yang B
Biomater Sci; 2020 Oct; 8(19):5241-5259. PubMed ID: 32996922
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.
Ji B; Wei M; Yang B
Theranostics; 2022; 12(1):434-458. PubMed ID: 34987658
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional nanomedicines for synergistic photodynamic immunotherapy based on tumor immune microenvironment.
Guo R; Liu Y; Xu N; Ling G; Zhang P
Eur J Pharm Biopharm; 2022 Apr; 173():103-120. PubMed ID: 35283303
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy.
Lee ES; Shin JM; Son S; Ko H; Um W; Song SH; Lee JA; Park JH
Adv Healthc Mater; 2019 Feb; 8(4):e1801320. PubMed ID: 30666822
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer.
Wang J; Zhou M; Chen F; Liu X; Gao J; Wang W; Wang H; Yu H
J Biomed Nanotechnol; 2021 Aug; 17(8):1486-1509. PubMed ID: 34544528
[TBL] [Abstract][Full Text] [Related]
15. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
Jin F; Liu D; Xu X; Ji J; Du Y
Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species-powered cancer immunotherapy: Current status and challenges.
He M; Wang M; Xu T; Zhang M; Dai H; Wang C; Ding D; Zhong Z
J Control Release; 2023 Apr; 356():623-648. PubMed ID: 36868519
[TBL] [Abstract][Full Text] [Related]
17. Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy.
Cheng D; Wang X; Zhou X; Li J
Front Bioeng Biotechnol; 2021; 9():761218. PubMed ID: 34660560
[TBL] [Abstract][Full Text] [Related]
18. Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy.
Li W; Peng A; Wu H; Quan Y; Li Y; Lu L; Cui M
Front Immunol; 2020; 11():601497. PubMed ID: 33408716
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies.
Zafar A; Hasan M; Tariq T; Dai Z
Bioconjug Chem; 2022 Jun; 33(6):1011-1034. PubMed ID: 34793138
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.
Zhang P; Zhai Y; Cai Y; Zhao Y; Li Y
Adv Mater; 2019 Dec; 31(49):e1904156. PubMed ID: 31566275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]